Showing results (41-50 of 98) with videos related to

Sort By:
Pageof 10
Journal of Clinical Microbiology|September 8, 2021
Use of Fosfomycin Etest To Determine In Vitro Susceptibility of Clinical Isolates of Enterobacterales Other than Escherichia coli, Nonfermenting Gram-Negative Bacilli, and Gram-Positive CocciJames A Karlowsky, Melanie R Baxter, Alyssa R Golden, et al.
The Journal of Antimicrobial Chemotherapy|August 16, 2022
In vitro activity of fosfomycin against bacterial pathogens isolated from urine specimens in Canada from 2007 to 2020: CANWARD surveillance studyJames A Karlowsky, Melanie R Baxter, Andrew J Walkty, et al.
Diagnostic Microbiology and Infectious Disease|February 20, 2018
PCR ribotyping and antimicrobial susceptibility testing of isolates of Clostridium difficile cultured from toxin-positive diarrheal stools of patients receiving medical care in Canadian hospitals: the Canadian Clostridium difficile Surveillance Study (CAN-DIFF) 2013-2015James A Karlowsky, Heather J Adam, Tyler Kosowan, et al.
The Journal of Antimicrobial Chemotherapy|August 28, 2025
Increasing rates of ESBL-producing Escherichia coli and Klebsiella pneumoniae in Canadian Hospitals: 17 years of the CANWARD study, 2007-23Philippe Lagacé-Wiens, Laura Mataseje, Melissa McCracken, et al.
International Journal of Antimicrobial Agents|April 30, 2019
In vitro susceptibility of urinary Escherichia coli isolates to first- and second-line empirically prescribed oral antimicrobials: CANWARD surveillance study results for Canadian outpatients, 2007-2016James A Karlowsky, Philippe R S Lagacé-Wiens, Heather J Adam, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Species distribution and antifungal susceptibility of invasive Candida isolates from Canadian hospitals: results of the CANWARD 2011-16 studyJeff Fuller, Tanis C Dingle, Amy Bull, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2019
Characterization of MRSA in Canada from 2007 to 2016Kimberly A Nichol, Heather J Adam, George R Golding, et al.
The Journal of Antimicrobial Chemotherapy|April 17, 2013
Changing epidemiology of methicillin-resistant Staphylococcus aureus in CanadaKimberly A Nichol, Heather J Adam, Diane L Roscoe, et al.
Antimicrobial Agents and Chemotherapy|December 11, 2013
In Vitro activity of fosfomycin against Escherichia coli isolated from patients with urinary tract infections in Canada as part of the CANWARD surveillance studyJames A Karlowsky, Andrew J Denisuik, Philippe R S Lagacé-Wiens, et al.
Antimicrobial Agents and Chemotherapy|August 28, 2013
In vitro activity of ceftaroline-avibactam against gram-negative and gram-positive pathogens isolated from patients in Canadian hospitals from 2010 to 2012: results from the CANWARD surveillance studyJames A Karlowsky, Heather J Adam, Melanie R Baxter, et al.
Pageof 10